Menu

Arena Pharmaceuticals, Inc. ARNA

Full chart Compare
Set alert

Price alert · ARNA

All alert types
99.99 +99.99

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $12.03MExpenses → Selling, General & Admin: $126.21MExpenses → Research & Development: $419.51MExpenses → Other Operating Expenses: $78.64MExpenses → Interest Expense: $4.16MGross Profit → Expenses: $54.00KRevenue → Gross Profit: $54.00KNet Loss → Expenses: $616.43MOther Income$12.03MGross Profit$54.00KNet Loss$616.43MExpenses$628.51MSelling, General & Admin$126.21MResearch & Development$419.51MOther Operating Expenses$78.64MInterest Expense$4.16MRevenue$54.00K

Latest period ending Dec 31, 2021 · select a line to chart its full history

ARNA annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
54.00K319.00K806.43M17.97M21.34M
54.00K319.00K806.43M17.97M21.34M
-624.30M-426.64M482.75M-144.78M-91.97M
-616.43M-404.73M397.56M-29.40M-91.41M
-10.14-7.397.69-0.63-2.77
ARNA annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
224.57M219.54M243.27M161.04M158.84M
784.71M1.19B1.17B686.90M339.27M
111.47M110.25M102.66M80.64M132.13M
41.21M45.61M49.43M52.71M61.75M
673.24M1.08B1.07B606.26M207.14M
ARNA annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-452.02M-353.09M568.69M-132.21M-66.64M
321.40M-21.40M-496.95M-251.27M-112.39M
135.41M350.61M9.87M385.03M245.29M
-988.00K-820.00K-4.82M-692.00K676.00K
5.03M-23.73M81.60M2.20M68.13M